Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neuronal gene transcription modulates demyelination and remyelination in a mouse model of multiple sclerosis.
Dimethylfumarate Impairs Neutrophil Functions.
Differential effects of myelin basic protein-activated Th1 and Th2 cells on the local immune microenvironment of injured spinal cord.
Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study.
Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Multiple Sclerosis.
Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis.
Multiple sclerosis or neurological manifestations of Celiac disease.
In vitro-induced cell-mediated immune deviation to encephalitogenic antigens.
Lesser-known myelin-related disorders: Focal tumour-like demyelinating lesions.
Multiple sclerosis and neurofibromatosis type 1: report of seven patients from Iran.
Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis.
Treatment Costs and Patterns In Patients With Multiple Sclerosis Treated With Prolonged-Release Fampridine In Germany.
Guwiyang Wurra-'Fire Mouse': a global gene knockout model for TSPO/PBR drug development, loss-of-function and mechanisms of compensation studies.
Spinster 2, a sphingosine-1-phosphate transporter, plays a critical role in inflammatory and autoimmune diseases.
Can Antibodies Against Glial Derived Antigens be Early Biomarkers of Hippocampal Demyelination and Memory Loss in Alzheimer's Disease?
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region.
Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
Progression, Symptoms and Psychosocial Concerns among Those Severely Affected by Multiple Sclerosis: A Mixed-Methods Cross-Sectional Study of Black Caribbean and White British People.
A comprehensive approach to the segmentation of multichannel three-dimensional MR brain images in multiple sclerosis.
Normal Diffusion-Weighted MRI During the Acute Stage of Central Pontine Myelinolysis.
Successful antiviral treatment of chronic hepatitis C in patients with rare comorbidities. Two case-reports.
Vaccines in Multiple Sclerosis.
Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
Another Case of PML with Gilenya Reported by Novartis
[Animal models of Charcot-Marie-Tooth disease and their relevance for understanding the disease in humans.]
Pages
« first
‹ previous
…
707
708
709
710
711
712
713
714
715
…
next ›
last »